共 7 条
[1]
[Anonymous], 2014, Guidance for Industry: Expedited Programs for Serious Conditions Drugs and Biologics
[4]
Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2017, 318 (07)
:626-636
[6]
Need for a National Evaluation System for Health Technology
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2016, 316 (11)
:1153-1154
[7]
Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2017, 318 (07)
:619-625